Invention Grant
- Patent Title: Compositions targeting GABRA2 and methods for diagnosis and treatment of cancer
-
Application No.: US17263251Application Date: 2019-07-25
-
Publication No.: US12134650B2Publication Date: 2024-11-05
- Inventor: Benjamin Dekel , Orit Harari-Steinberg , Sanja Goldberg
- Applicant: Tel HaShomer Medical Research Infrastructure and Services Ltd. , Tageza Biopharmaceuticals Ltd.
- Applicant Address: IL Ramat-Gan; IL Tel Aviv
- Assignee: Tel HaShomer Medical Research Infrastructure and Services Ltd.,Tageza Biopharmaceuticals Ltd.
- Current Assignee: Tel HaShomer Medical Research Infrastructure and Services Ltd.,Tageza Biopharmaceuticals Ltd.
- Current Assignee Address: IL Ramat-Gan; IL Tel Aviv
- International Application: PCT/IL2019/050849 WO 20190725
- International Announcement: WO2020/021556 WO 20200130
- Main IPC: A61K35/17
- IPC: A61K35/17 ; A61K47/68 ; C07K16/28 ; C12Q1/6886 ; G01N33/574

Abstract:
Methods of treating cancer are provided. Accordingly, there is provided a method of treating cancer in a subject in need thereof, the method comprising administering to the subject an effective amount of an agent capable of (i) specifically binding GABRA2, the agent comprising a therapeutic moiety; and/or (ii) downregulating activity and/or expression of said GABRA2. Also provided are compositions, article of manufactures and methods of diagnosing cancer and monitoring cancer treatment.
Public/Granted literature
- US20210163591A1 COMPOSITIONS TARGETING GABRA2 AND METHODS FOR DIAGNOSIS AND TREATMENT OF CANCER Public/Granted day:2021-06-03
Information query
IPC分类: